Bea Binag

Bea Binag is a Clinical Data Scientist specializing in oncology clinical trials, boasting over ten years of experience in clinical operations and data management. They previously served as a Senior Clinical Data Associate at Seagen, where they played a key role in the FDA approval of Tucatinib for metastatic colorectal cancer. Bea's educational background includes a Bachelor's degree in Biochemistry from the University of Washington, and they have held various positions at notable institutions, including UW Medicine, Fred Hutch, and Seattle Cancer Care Alliance. Currently, Bea works as a Manager and Senior Clinical Data Scientist at Pfizer.